Spinocerebellar Degeneration
📧 Sign up to get email alerts when something new happens for Spinocerebellar Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration [Phase 3]
Kissei Pharmaceutical's Phase 3 confirmatory trial of KPS-0373 for spinocerebellar degeneration is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration [Phase 4]
Phase 4 trial update for C-Trelin oral disintegrating tablet 5 mg in ataxia due to spinocerebellar degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 3]
A Phase 3 confirmatory study of KPS-0373 in spinocerebellar degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 3]
A Phase 3 confirmatory study of KPS-0373 in spinocerebellar degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 3]
A 24-week open-label Phase 3 trial of KPS-0373 for Spinocerebellar Degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 3]
A Phase 3 long-term study evaluating KPS-0373 in Spinocerebellar Degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 3]
This document reports the completion of an extension study of KPS-0373 in spinocerebellar degeneration in a Phase 3 setting.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]
A Phase II double-blind trial of KPS-0373 in Spinocerebellar degeneration has completed. The study identifier is NCT01384435.
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]
A Phase 2 clinical trial of KPS-0373 for spinocerebellar degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]
Phase II clinical trial of KPS-0373 for Spinocerebellar Degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration [Phase 2]
A Phase 2 clinical trial evaluating high-dose intravenous immunoglobulin for spinocerebellar degeneration has completed its status.